Glenmark Generics Ltd.

GPTKB entity

Properties (55)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition nan
gptkbp:advertising focus on high-value generics
gptkbp:awards various industry awards
gptkbp:businessModel generic_and_specialty_pharmaceuticals
gptkbp:CEO gptkb:Glenn_Saldanha
gptkbp:clinicalTrials ongoing
innovative therapies
in-house and outsourced
gptkbp:collaborations various partnerships.
gptkbp:community_engagement healthcare_initiatives
gptkbp:customerBase hospitals and pharmacies
gptkbp:employees over 10,000
gptkbp:financialPerformance consistent growth
gptkbp:founded 1977
gptkbp:founder gptkb:Glenn_Saldanha
gptkbp:future_plans expansion in emerging markets
gptkbp:global_presence over 80 countries
gptkbp:headquarters gptkb:Mumbai
gptkb:Mumbai,_India
https://www.w3.org/2000/01/rdf-schema#label Glenmark Generics Ltd.
gptkbp:industry pharmaceuticals
gptkbp:investmentFocus transparent communication
R&D investments
gptkbp:market global
approximately $3 billion
gptkbp:notableEvent high standards
gptkbp:partnerships academic institutions
various global pharmaceutical companies
gptkbp:patentCitation numerous
gptkbp:productionLocation multiple locations
gptkbp:productLine diverse portfolio
gptkbp:products generic drugs
gptkbp:regulatoryCompliance FDA,_EMA
gptkbp:research_areas diabetes
neurology
oncology
dermatology
infectious diseases
ophthalmology
urology
gastroenterology
cardiovascular
respiratory
gptkbp:researchAndDevelopment focus on chronic diseases
gptkbp:revenue over $1 billion
gptkbp:services contract manufacturing
gptkbp:social_responsibility health and education programs
gptkbp:stockExchange gptkb:BSE
GLENMARK
gptkbp:subsidiary gptkb:Glenmark_Pharmaceuticals_Inc.
gptkbp:supplyChain efficient and reliable
gptkbp:sustainability_initiatives environmental responsibility
gptkbp:team experienced professionals
gptkbp:website www.glenmarkpharma.com